Vanderbilt research finds that the U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

Vanderbilt University Medical Center is piloting several new physical security measures, including metal detectors.

Vanderbilt University Medical Center (VUMC) is piloting several new physical security measures, including metal detectors, starting in May.

Vanderbilt research shows a common anesthesia drug could be beneficial in reducing pressure inside the skull of children with traumatic brain injuries.

A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.

More than 75% of patients facing amputation from the most severe form of peripheral artery disease were able to keep their limb after an innovative treatment as part of a multicenter study published in the New England Journal of Medicine.